Skip to main content

What is Triple negative #breast #cancer ( #TripleNegativeBreastCancer ) ?

Triple negative breast cancer is an uncommon type of breast cancer whose cells don’t have receptors for: the hormones 1. oestrogen 2. progesterone and 3. Her2 protein 
Your doctor uses a sample of your cancer to test the cells for these receptors. You might have this testing following a biopsy of the cancer, or after surgery to remove it. A rare type of breast cancer known as basal type breast cancer is usually triple negative. 

Some women with triple negative breast cancer also have a BRCA1 gene fault. 
BRCA1 is one of the gene faults that can increase the risk of breast cancer within families. 
Some men have triple negative breast cancer but this is very rare. 
Most men have oestrogen receptors in their cancer cells. 

Breast cancer receptors 
Some cancer cells have particular proteins called receptors. When certain substances in the body attach to the receptors, they trigger a reaction in the cancer cells that tell them to grow. Oestrogen attaches to oestrogen receptors Progesterone attaches to progesterone receptors Her2 attaches to Her2 receptors Many breast cancers have receptors for one or more of these substances. But triple negative breast cancers don’t have any of them. So hormone treatment and the targeted cancer drug trastuzumab (Herceptin) don't work for people with triple negative breast cancer. There are other drugs available to treat triple negative breast cancer. 

Around 15 out of every 100 breast cancers (15%) are triple negative. 

The symptoms of triple negative breast cancer are similar to other breast cancer types. Symptoms can include: 
 a new lump or thickening in your breast or armpit 
a change in size, shape or feel of your breast 
skin changes in the breast such as puckering, dimpling, a rash or redness of the skin 
fluid leaking from the nipple in a woman who isn’t pregnant or breast feeding 
changes in the position of nipple 
Make an appointment to see your doctor if you notice anything different or unusual about the look and feel of your breasts.

Share this trusted information.


Popular posts from this blog

#COVID-19 #Vaccines and #Vaccination

  Key Points Available evidence suggests the currently authorized mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna) provide protection against a variety of strains, including B.1.1.7 (originally identified in the United Kingdom) and B.1.351 (originally identified in South Africa). Other vaccines show reduced efficacy against B.1.351 but may still protect against severe disease. Continued monitoring of vaccine effectiveness against variants is needed. A growing body of evidence indicates that people fully vaccinated with an mRNA vaccine (Pfizer-BioNTech and Moderna) are less likely to have asymptomatic infection or to transmit SARS-CoV-2 to others. Studies are underway to learn more about the benefits of Johnson & Johnson/Janssen vaccine. However, the risk for SARS-CoV-2 infection in fully vaccinated people cannot be completely eliminated as long as there is continued community transmission of the virus. At this time, there are limited data on vaccine effectiveness in people who

Frequently Asked Questions about #COVID-19 #Vaccination

If I have already had COVID-19 and recovered, do I still need to get vaccinated with a COVID-19 vaccine? Yes, you should be vaccinated regardless of whether you already had COVID-19. That’s because experts do not yet know how long you are protected from getting sick again after recovering from COVID-19. Even if you have already recovered from COVID-19, it is possible—although rare—that you could be infected with the virus that causes COVID-19 again. Studies have shown that vaccination provides a strong boost in protection in people who have recovered from COVID-19. Learn more about why getting vaccinated is a safer way to build protection than getting infected. If you were treated for COVID-19 with monoclonal antibodies or convalescent plasma, you should wait 90 days before getting a COVID-19 vaccine. Talk to your doctor if you are unsure what treatments you received or if you have more questions about getting a COVID-19 vaccine. If you or your child has a history of multisystem inflam

COVID 19 - Delta and Delta Plus Variant

SARS-CoV-2 Delta variant, also known as lineage B.1.617.2, is a variant of lineage B.1.617 of SARS-CoV-2, the virus that causes COVID-19. It was first detected in India in late 2020. The World Health Organization (WHO) named it the Delta variant on 31 May 2021. It has mutations in the gene encoding the SARS-CoV-2 spike protein causing the substitutions T478K, P681R and L452R, which are known to affect the transmissibility of the virus as well as whether it can be neutralised by antibodies for previously circulating variants of the COVID-19 virus. Public Health England (PHE) in May 2021 observed secondary attack rates to be 51–67% higher than the alpha variant. On 7 May 2021, PHE changed their classification of lineage B.1.617.2 from a variant under investigation (VUI) to a variant of concern (VOC) based on an assessment of transmissibility being at least equivalent to B.1.1.7 (Alpha variant); the UK's SAGE subsequently estimated a "realistic" possibility of being 50% mor